PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial - Raal, F J; Stein, E A; Dufour, RRUTHERFORD-2 Investigators (Lancet, 2015)
et al.